Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA as Adjuvant Treatment for Rhegmatogenous Retinal Detachment
NCT02841306Phase 1Completed
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of ursodeoxycholic acid in rhegmatogenous retinal detachment (RRD). Started Jul 2016; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on NCT02841306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841306.